About

Peter Hug, Ph.D., has served as a member of ADC Therapeutics' board of directors since June 2019 and serves as Lead Independent Director and Vice-Chairman. From 1983 to 2018 he served in various positions at F. Hoffmann-La Roche Ltd., including head of Roche Pharma EEMEA region, head of Roche Pharma Europe region and Executive Vice President of Roche Pharma Partnering. Dr. Hug holds a Ph.D. in economics from the University of Basel.

Roles

ADC Therapeutics SA
Lead Independent Director and Vice-Chairman · Current role
June 2019–present
ADC Therapeutics
Lead Independent Director and Vice-Chairman
June 2019 - present
F. Hoffmann-La Roche Ltd.
Head of Roche Pharma EEMEA / Europe region; EVP Roche Pharma Partnering
1983 - 2018

External Roles

Mundipharma MEA
Board member
—
AC BioScience
Board member
—

Director Compensation

FY 2025
Fees earned or paid in cash
$90,000
ComponentAnnual cash retainer plus committee and leadership retainers earned in fiscal 2025
Stock awards
$143,600
ComponentAnnual RSU grant, ASC 718 grant-date fair value
All other compensation
$17,368
ComponentSocial security contributions and certain non-mandatory local benefits
Total
$250,968

Also at ADC Therapeutics SA

Colleague
Ameet Mallik
Chief Executive Officer and Director
Colleague
Jose “Pepe” Carmona
Chief Financial Officer
Colleague
Mohamed Zaki
Chief Medical Officer

Related

Company
ADC Therapeutics SA
Company hub

See how VectorShift works for your firm

Request Demo